MAGeCK

MAGeCK analyzes genome-scale CRISPR-Cas9 knockout screen data to identify essential genes and estimate single-guide RNA (sgRNA) knockout efficiencies for functional genomics studies.


Key Features:

  • Quality Control Measures: Provides comprehensive QC metrics to evaluate the integrity and reliability of CRISPR-Cas9 screen data.
  • Maximum-Likelihood Algorithm: Implements a maximum-likelihood algorithm using a generalized linear model to identify essential genes across multiple conditions and deconvolute effects in CRISPR screen data.
  • Expectation-Maximization Technique: Uses an expectation-maximization approach to iteratively estimate sgRNA knockout efficiency and gene essentiality.
  • Interactive Visualization Framework (VISPR): Includes VISPR for interactive visualization and exploration of QC metrics and analysis results from CRISPR-Cas9 screens.

Scientific Applications:

  • Essential Gene Identification: Systematically identify genes essential under various experimental conditions from CRISPR-Cas9 knockout screens.
  • Functional Genomics: Support investigations into gene function and interaction networks using genome-scale perturbation data.
  • Comparative Condition Analysis: Compare gene essentiality across multiple conditions to inform basic and applied biomedical studies.

Methodology:

Performs quality-control assessments, applies maximum-likelihood estimation via a generalized linear model to deconvolute screen effects, and uses expectation-maximization to iteratively estimate sgRNA efficiencies and gene essentiality, with VISPR for visualization.

Topics

Details

Tool Type:
command-line tool
Operating Systems:
Linux, Windows
Programming Languages:
Python
Added:
8/3/2017
Last Updated:
11/25/2024

Operations

Publications

Li W, Köster J, Xu H, Chen C, Xiao T, Liu JS, Brown M, Liu XS. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biology. 2015;16(1). doi:10.1186/s13059-015-0843-6. PMID:26673418. PMCID:PMC4699372.

PMID: 26673418
PMCID: PMC4699372
Funding: - National Institutes of Health: R01 GM113242-01, U01 CA180980 - National Science Foundation: DMS-1120368 - Dana-Farber Cancer Institute: Claudia Adams Barr Award in Innovative Basic Cancer Research - National Human Genome Research Institute: R01 HG008728

Documentation

Links